X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs TORRENT PHARMA - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD TORRENT PHARMA LUPIN LTD/
TORRENT PHARMA
 
P/E (TTM) x 22.8 29.0 78.4% View Chart
P/BV x 3.1 5.5 55.9% View Chart
Dividend Yield % 0.8 1.0 82.4%  

Financials

 LUPIN LTD   TORRENT PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
TORRENT PHARMA
Mar-17
LUPIN LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7501,768 99.0%   
Low Rs1,3841,186 116.7%   
Sales per share (Unadj.) Rs387.4346.1 111.9%  
Earnings per share (Unadj.) Rs56.655.2 102.7%  
Cash flow per share (Unadj.) Rs76.873.3 104.8%  
Dividends per share (Unadj.) Rs7.5014.00 53.6%  
Dividend yield (eoy) %0.50.9 50.5%  
Book value per share (Unadj.) Rs298.9257.1 116.3%  
Shares outstanding (eoy) m451.58169.22 266.9%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.04.3 94.8%   
Avg P/E ratio x27.726.8 103.4%  
P/CF ratio (eoy) x20.420.1 101.2%  
Price / Book Value ratio x5.25.7 91.3%  
Dividend payout %13.225.4 52.2%   
Avg Mkt Cap Rs m707,513249,887 283.1%   
No. of employees `00016.811.8 142.5%   
Total wages/salary Rs m28,4959,934 286.8%   
Avg. sales/employee Rs Th10,418.34,971.5 209.6%   
Avg. wages/employee Rs Th1,697.0843.2 201.2%   
Avg. net profit/employee Rs Th1,523.0792.4 192.2%   
INCOME DATA
Net Sales Rs m174,94358,569 298.7%  
Other income Rs m1,0652,233 47.7%   
Total revenues Rs m176,00860,802 289.5%   
Gross profit Rs m44,93113,773 326.2%  
Depreciation Rs m9,1223,069 297.2%   
Interest Rs m1,5252,056 74.2%   
Profit before tax Rs m35,34910,881 324.9%   
Minority Interest Rs m-720-   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,7851,545 633.3%   
Profit after tax Rs m25,5759,336 273.9%  
Gross profit margin %25.723.5 109.2%  
Effective tax rate %27.714.2 194.9%   
Net profit margin %14.615.9 91.7%  
BALANCE SHEET DATA
Current assets Rs m119,54253,841 222.0%   
Current liabilities Rs m61,20631,612 193.6%   
Net working cap to sales %33.338.0 87.9%  
Current ratio x2.01.7 114.7%  
Inventory Days Days7697 78.2%  
Debtors Days Days9084 107.3%  
Net fixed assets Rs m131,66042,079 312.9%   
Share capital Rs m903846 106.7%   
"Free" reserves Rs m134,07342,655 314.3%   
Net worth Rs m134,97643,501 310.3%   
Long term debt Rs m56,47822,408 252.0%   
Total assets Rs m266,073101,250 262.8%  
Interest coverage x24.26.3 384.1%   
Debt to equity ratio x0.40.5 81.2%  
Sales to assets ratio x0.70.6 113.7%   
Return on assets %10.211.3 90.5%  
Return on equity %18.921.5 88.3%  
Return on capital %19.319.6 98.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m81,88520,066 408.1%   
Fx outflow Rs m21,5065,304 405.5%   
Net fx Rs m60,37814,762 409.0%   
CASH FLOW
From Operations Rs m41,14810,127 406.3%  
From Investments Rs m-25,287-7,869 321.3%  
From Financial Activity Rs m4,332-1,918 -225.8%  
Net Cashflow Rs m20,193212 9,547.3%  

Share Holding

Indian Promoters % 46.6 71.5 65.2%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 7.0 161.0%  
FIIs % 31.9 12.6 253.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 8.8 114.8%  
Shareholders   98,259 26,511 370.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS